A general approach to antibody thermostabilization

Citations Over TimeTop 14% of 2014 papers

Abstract

Antibody engineering to enhance thermostability may enable further application and ease of use of antibodies across a number of different areas. A modified human IgG framework has been developed through a combination of engineering approaches, which can be used to stabilize antibodies of diverse specificity. This is achieved through a combination of complementarity-determining region (CDR)-grafting onto the stable framework, mammalian cell display and in vitro somatic hypermutation (SHM). This approach allows both stabilization and maturation to affinities beyond those of the original antibody, as shown by the stabilization of an anti-HA33 antibody by approximately 10°C and affinity maturation of approximately 300-fold over the original antibody. Specificities of 10 antibodies of diverse origin were successfully transferred to the stable framework through CDR-grafting, with 8 of these successfully stabilized, including the therapeutic antibodies adalimumab, stabilized by 9.9°C, denosumab, stabilized by 7°C, cetuximab stabilized by 6.9°C and to a lesser extent trastuzumab stabilized by 0.8°C. This data suggests that this approach may be broadly useful for improving the biophysical characteristics of antibodies across a number of applications.

Related Papers

• → Ig VH hypermutation is absent in the germinal centers of aged mice(1995)123 cited
• → Affinity maturation and hypermutation in a simulation of the humoral immune response(1996)122 cited
• → The Use of Somatic Hypermutation for the Affinity Maturation of Therapeutic Antibodies(2018)8 cited
• → Somatic Evolution in the Immune System: The Need for Germinal Centers for Efficient Affinity Maturation(1997)20 cited
• → B cells from aged mice do not have intrinsic defects in affinity maturation(2023)1 cited